Skip to main content

Structure, Properties, and Drug-likeness of Pharmaceuticals That Inhibit Ebola Virus Disease (EVD) Proliferation | Chapter 01 | Current Trends in Disease and Health Vol. 1

Introduction: The Ebola virus is one of known viruses within the genus Ebolavirus that are generally considered to cause Ebola virus disease (EBV) in humans. Some investigators have determined that Ebola virus outbreaks have an increased likelihood to occur when temperatures are lower and humidity is higher. The determination and evaluation of pharmacokinetic and pharmacodynamics properties of drugs potentially useful for treatment of Ebola virus disease is a very important consideration for discovery of new pharmaceuticals.


Aims:
To present the molecular structures of compounds that has been shown to inhibit the proliferation of Ebola virus. To elucidate the molecular properties of these virus inhibiting compounds.

Study Design: The molecular properties of virus inhibiting compounds are elucidated and compiled. Pattern recognition methods and statistical analysis are applied to determine optimal properties of this group of compounds.

Place and Duration of Study: Chemistry Department, Durham Science Center, University of Nebraska, Omaha NE. between December 2015 and February 2016.

Methodology: A total of 60 compounds were identified as inhibiting the virus Ebola. The molecular properties such as Log P, molecular weight, and 7 other descriptors were elucidated utilizing heuristic methods. Structures are compared by applying classification methods with statistical tests to determine trends, underlying relationships, and pattern recognition.

Results: For 60 compounds identified the averages determined: for Log P (3.51), polar surface area (89.45 Angstroms2), molecular weight (432.6), molecular volume (393.96 Angstroms3), and number of rotatable bonds (7). Molecular weight showed a strong positive correlation to number of oxygen and nitrogen atoms, number of rotatable bonds, and molecular volume. K-means clustering indicated seven clusters divided according to highest similarity of members in the cluster. Ranges found: formula weights (157.1 to 822.94), Log P (-2.24 to 8.93), polar surface area (6.48 to 267.04 A2), and number of atoms (11 to 58). Multiple regression analysis produced an algorithm to predict similar compounds.

Conclusion: The formula weights and Log P values of Ebola virus inhibitors show a broad range in numerical values. Consistency in properties was identified by statistical analysis with grouping for similarity by K-means pattern recognition. Multiple regression analysis enables prediction of similar compounds as drug candidates. Only 29 compounds showed zero violations of rule of 5, an indication of favorable drug-likeness. These compounds are highly varied in structures and properties.

Author(s) Details

Dr. Ronald Bartzatt
University of Nebraska, Durham Science Center, 6001 Dodge Street, Omaha, Nebraska 68182, USA.

View Volume: https://doi.org/10.9734/bpi/ctdah/v1

Comments

Popular posts from this blog

A Brief Study of Middleware Technologies: Programming Applications and Management Systems | Chapter 15 | Novel Research Aspects in Mathematical and Computer Science Vol. 1

  Many platforms, services, applications, hardware, and operating systems are connected through the middleware layer. Because the middleware layer abstracts much low-level complexity and makes applications and software systems portable, it allows disparate systems to interface and function together in harmony. Middleware technologies enable software engineers to swiftly construct software systems and applications, allowing developers to focus on more important tasks. This chapter examines several types of middleware systems and discusses middleware capabilities, middleware operation, middleware's function in cloud-based systems, and the best middleware platforms to use. Middleware systems are widely utilised and can be found in practically any software system or application. Middleware programmes provide as a link between many sorts of systems and protocols. They serve as a mechanism for various systems. To successfully exchange information, it runs on a variety of operating system

A Prospective Study about Safety and Efficacy of Perioperative Lidocaine Infusion | Chapter 09 | New Horizons in Medicine and Medical Research Vol. 8

 Opioids cause clinically significant side effects such as respiratory depression, immunosuppression, muscle rigidity, negative inotropism, nausea, vomiting, hyperalgesia, urine retention, postoperative ileus, and drowsiness. Perioperative opioids are a major contributor to the United States' and other countries' opioid epidemics. Non-opioid analgesics, particularly lidocaine, are becoming more common for perioperative use as a result of this. A total of 185 adult patients were randomly assigned to one of two groups: control group I (105 patients) [fentanyl group] or group ii (80 patients) [opioid-free anaesthesia group]. Lidocaine 1.5 mg/kg bolus followed by 1.5 mg/kg/h infusion intraoperatively, and 1.5-2 mg/kg/h infusion for 2-8 hours postoperatively were given to patients in both groups at anaesthetic induction. Intraoperatively, both groups received analgesic adjuvants such as diclofenac 75 mg, paracetamol 1 gm, and mgso4 30-50 mg/kg. If the mean arterial pressure (map)

Ethnopharmacological Survey among Traditional Medicine Practitioners in Abidjan (Côte d'Ivoire) for the Management of Pathologies such as Malaria, ENT Diseases, Diarrhea, Typhoid Fever and Anemia | Chapter 05 | New Horizons in Medicine and Medical Research Vol. 8

 Traditional Medicine Practitioners (TMPs) of Côte d'Ivoire are familiar with the therapeutic herbs. Medicinal plants have been shown to be useful in the treatment of common diseases such as malaria (KROA, 2004) and diabetes (N'GUESSAN et al, 2013) in several studies and scientific study. In the Abidjan District, the current policy is to integrate traditional medicine and pharmacopoeia into the national health system in order to improve population health coverage, particularly in the management of commonly encountered diseases such as malaria, ENT diseases, diarrhoea, typhoid fever, and anaemia. This research aims to increase the use of traditional medicine and pharmacopoeia in the national health system. Over the course of three months, fifty (50) PMTs in the District of Abidjan participated in this study. Plant therapists accounted for 30 of the 50 PMTs polled at the end of the study, or 60%. Traditional medicine centres use 61 types of medicinal plants from 36 famili